Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib with Docetaxel and Radiation in Head and Neck Cancer
NCT00720304Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Nov 2007
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in head and neck squamous cell carcinoma (HNSCC), sponsored by Case Comprehensive Cancer Center. Started Nov 2007; status: completed.
02
Drugs
erlotinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00720304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00720304.